Skip to main content

Table 2 Clinical characteristics of tuberculosis patients by HIV Status (n = 10,156)

From: Tuberculosis treatment outcomes: a fifteen-year retrospective study in Jos-North and Mangu, Plateau State, North - Central Nigeria

Variable HIV Negative (n = 3733) Freq. (%) HIV Positive (n = 2968) Freq. (%) Unknown HIV Status (n = 3455) Freq. (%) Total Freq. (%)
TB Diagnosis
 Pulmonary TB 3311 (88.7) 2818 (94.9) 3258 (94.3) 9387 (92.4)
 Extra-PTB 422 (11.3) 150 (5.1) 197 (5.7) 769 (7.6)
 TB Spine 227 (6.1) 29 (1.0) 92 (2.7) 348 (3.4)
 TB Adenitis 39 (1.0) 22 (0.7) 19 (0.5) 80 (0.8)
 TB Abdomen 135 (3.6) 91 (3.1) 61 (1.8) 287 (2.8)
 Othersa 21 (0.6) 8 (0.3) 25 (0.7) 54 (0.5)
TB Category
 New 3405 (91.2) 2778 (93.6) 3290 (95.2) 9473 (93.3)
 RAD/TALF 104 (2.8) 59 (2.0) 55 (1.6) 218 (2.1)
 Relapse 161 (4.3) 72 (2.4) 49 (1.4) 282 (2.8)
 Trt. Failure 11 (0.3) 7 (0.2) 1 (0.0) 19 (0.2)
 Transfer-In 52 (1.4) 52 (1.8) 60 (1.7) 164 (1.6)
Needing Retreatment
 No 3290 (88.1) 2704 (91.1) 2979 (86.2) 8973 (88.4)
 Yes 282 (7.6) 136 (4.6) 104 (3.0) 522 (5.1)
 Indeterminateb 161 (4.3) 128 (4.3) 372 (10.8) 661 (6.5)
Sputum AFB on Diagnosis
 Sputum Negative 2355 (63.1) 2398 (80.8) 2480 (71.8) 7233 (71.2)
 Sputum AFB Positive 1378 (36.9) 570 (19.2) 975 (28.2) 2923 (28.8)
Sputum AFB After Intensive Phase
 Sputum Negative 3510 (94.0) 2806 (94.5) 3044 (88.1) 9360 (92.2)
 Sputum AFB Positive 39 (1.0) 18 (0.6) 12 (0.3) 69 (0.7)
 Indeterminateb 184 (4.9) 144 (4.9) 398 (11.5) 726 (7.1)
Defaulting Period (n = 1874)
 During Intensive Phase 97 (2.6) 65 (2.2) 271 (7.8) 433 (4.3)
 End of Intensive Phase 190 (5.1) 191 (6.4) 559 (16.2) 940 (9.3)
 Continuation Phase 96 (2.6) 62 (2.1) 343 (9.9) 501 (4.9)
Binary Outcome
 Unsuccessful 919 (24.6) 781 (26.3) 1599 (46.3) 3299 (32.5)
 Successful 2814 (75.4) 2187 (73.7) 1855 (53.7) 6856 (67.5)
  1. a=Disseminated TB, Miliary TB, Ovarian TB, Pleural TB, Skin TB, Heart TB
  2. bIndeterminate due to lost to follow-up or death during intensive phase of treatment RAD Return after Default, TALF Treatment after lost to follow up, Trt Treatment